TY - JOUR
T1 - Association between TDP-43 and mitochondria in inclusion body myositis
AU - Huntley, Mikayla L.
AU - Gao, Ju
AU - Termsarasab, Pichet
AU - Wang, Luwen
AU - Zeng, Sophia
AU - Thammongkolchai, Thananan
AU - Liu, Ying
AU - Cohen, Mark L.
AU - Wang, Xinglong
N1 - Publisher Copyright:
© 2019, United States & Canadian Academy of Pathology.
PY - 2019/7/1
Y1 - 2019/7/1
N2 - Inclusion body myositis (IBM) is the most common cause of primary myopathy in individuals aged 50 years and over, and is pathologically characterized by protein aggregates of p62 and mislocalized cytoplasmic TDP-43, as well as mitochondrial abnormalities in affected muscle fibers. Our recent studies have shown the accumulation of TDP-43 in mitochondria in neurons from patients with amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD), and revealed mitochondria as critical mediators of TDP-43 neurotoxicity. In this study, we investigated the association between mitochondria and TDP-43 in biopsied skeletal muscle samples from IBM patients. We found that IBM pathological markers TDP-43, phosphorylated TDP-43, and p62 all coexisted with intensively stained key subunits of mitochondrial oxidative phosphorylation complexes I–V in the same skeletal muscle fibers of patients with IBM. Further immunoblot analysis showed increased levels of TDP-43, truncated TDP-43, phosphorylated TDP-43, and p62, but decreased levels of key subunits of mitochondrial oxidative phosphorylation complexes I and III in IBM patients compared to aged matched control subjects. This is the first demonstration of the close association of TDP-43 accumulation with mitochondria in degenerating muscle fibers in IBM and this association may contribute to the development of mitochondrial dysfunction and pathological protein aggregates.
AB - Inclusion body myositis (IBM) is the most common cause of primary myopathy in individuals aged 50 years and over, and is pathologically characterized by protein aggregates of p62 and mislocalized cytoplasmic TDP-43, as well as mitochondrial abnormalities in affected muscle fibers. Our recent studies have shown the accumulation of TDP-43 in mitochondria in neurons from patients with amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD), and revealed mitochondria as critical mediators of TDP-43 neurotoxicity. In this study, we investigated the association between mitochondria and TDP-43 in biopsied skeletal muscle samples from IBM patients. We found that IBM pathological markers TDP-43, phosphorylated TDP-43, and p62 all coexisted with intensively stained key subunits of mitochondrial oxidative phosphorylation complexes I–V in the same skeletal muscle fibers of patients with IBM. Further immunoblot analysis showed increased levels of TDP-43, truncated TDP-43, phosphorylated TDP-43, and p62, but decreased levels of key subunits of mitochondrial oxidative phosphorylation complexes I and III in IBM patients compared to aged matched control subjects. This is the first demonstration of the close association of TDP-43 accumulation with mitochondria in degenerating muscle fibers in IBM and this association may contribute to the development of mitochondrial dysfunction and pathological protein aggregates.
UR - http://www.scopus.com/inward/record.url?scp=85061378759&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85061378759&partnerID=8YFLogxK
U2 - 10.1038/s41374-019-0233-x
DO - 10.1038/s41374-019-0233-x
M3 - Article
C2 - 30742062
AN - SCOPUS:85061378759
SN - 0023-6837
VL - 99
SP - 1041
EP - 1048
JO - Laboratory Investigation
JF - Laboratory Investigation
IS - 7
ER -